Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
57.90
+0.10 (0.17%)
Jun 23, 2026, 2:24 PM HKT

Vigonvita Life Sciences Revenue

In the year 2025, Vigonvita Life Sciences had annual revenue of 102.10M CNY with 762.88% growth.

Revenue
102.10M CNY
Revenue Growth
+762.88%
P/S Ratio
85.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.69B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025102.10M90.26M762.88%
Dec 31, 202411.83M-187.82M-94.07%
Dec 31, 2023199.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition